glp 1 agonist in ckd GLP-1 and the kidney: from physiology to pharmacology and outcomes diabetes SGLT2 Inhibitors and GLP-1 Receptor

In the SURMOUNT-5 head-to-head trial against semaglutide, tirzepatide at maximum dose produced 20.2% weight loss compared to semaglutide at 13.7%

Despite the closure of the Medicare Part D donut hole, many older adults still report financial hardship from prescription drug purchases, especially those with low income, multiple chronic conditions, or who take multiple medications daily

GLP-1 receptor agonists downregulate aberrant GnT-III expression in alzheimers disease models through the Akt/GSK-3beta/beta-catenin signaling

Hashimoto K, ed

Recent blogs GLP-1 Side Effects: Nausea, Digestive Changes and When to Call a Clinician Before you read This guide covers what side effects to expect on GLP-1 medications, how to reduce them, a